Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKurszieleVergleichProfilKnock-OutsSenden
OrderbuchRealtime StuttgartFundamentalanalyse InsidertradesFondsInvestmentreport
HistorischRealtime PushmyNewsAusblickim ForumAnleihen
Kaufen
Verkaufen
  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
30.06.15
MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
08.06.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
01.06.15
MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting (Globe Newswire)
01.06.15
MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting (Hugin)
31.05.15
MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASCO Meeting (Globe Newswire)
31.05.15
MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASCO Meeting (Hugin)
29.05.15
MorphoSys to Present at Five Upcoming Conferences (Globe Newswire)
29.05.15
MorphoSys to Present at Five Upcoming Conferences (Hugin)
22.05.15
MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
21.05.15
MorphoSys to Present Data on Proprietary Programs at 20th Congress of the European Hematology Association (Globe Newswire)
21.05.15
MorphoSys to Present Data on Proprietary Programs at 20th Congress of the European Hematology Association (Hugin)
13.05.15
MorphoSys to Present Data on Proprietary Programs at American Society of Clinical Oncology Annual Meeting (Globe Newswire)
13.05.15
MorphoSys to Present Data on Proprietary Programs at American Society of Clinical Oncology Annual Meeting (Hugin)
13.05.15
Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) (Hugin)
12.05.15
MorphoSys to Present at Two Upcoming Investor Conferences (Globe Newswire)
12.05.15
MorphoSys to Present at Two Upcoming Investor Conferences (Hugin)
08.05.15
Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members (Globe Newswire)
08.05.15
Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members (Hugin)
07.05.15
MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma (Globe Newswire)
07.05.15
MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma (Hugin)
07.05.15
Ad hoc: MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma (Hugin)
06.05.15
MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
05.05.15
MorphoSys AG Reports Results for the First Three Months of 2015 (Globe Newswire)
05.05.15
MorphoSys AG Reports Results for the First Three Months of 2015 (Hugin)
29.04.15
MorphoSys to Host Q1 2015 Conference Call on 05 May 2015 (Globe Newswire)
29.04.15
MorphoSys to Host Q1 2015 Conference Call on 05 May 2015 (Hugin)
21.04.15
MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution (Hugin)
14.04.15
MorphoSys to Present at Kempen & Co Life Sciences Conference (Globe Newswire)
14.04.15
MorphoSys to Present at Kempen & Co Life Sciences Conference (Hugin)
13.04.15
MorphoSys AG : MorphoSys to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis (Globe Newswire)
13.04.15
MorphoSys AG : MorphoSys to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis (Hugin)
08.04.15
MorphoSys to Start Share Buy-Back Program (Globe Newswire)
Seite: 12345

MorphoSys News

MorphoSys News: auf dieser Seite finden Sie alle MorphoSys News und Nachrichten zur MorphoSys Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MorphoSys News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um MorphoSys News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.